Lipid Luminations-logo

Lipid Luminations

ReachMD

"Lipid Luminations" is brought to you by the National Lipid Association. This program focuses on the field of lipidology, highlighting recent advances in lipid management and heart disease. Scientific and clinical research updates, new treatment options, best practices in patient care are just a few of the topics that will be examined on this program.

"Lipid Luminations" is brought to you by the National Lipid Association. This program focuses on the field of lipidology, highlighting recent advances in lipid management and heart disease. Scientific and clinical research updates, new treatment options, best practices in patient care are just a few of the topics that will be examined on this program.
More Information

Location:

Fort Washington, PA

Networks:

ReachMD

Description:

"Lipid Luminations" is brought to you by the National Lipid Association. This program focuses on the field of lipidology, highlighting recent advances in lipid management and heart disease. Scientific and clinical research updates, new treatment options, best practices in patient care are just a few of the topics that will be examined on this program.

Language:

English


Episodes

Million Hearts Initiative with Dr. Janet Wright, Executive Director

5/11/2015
More
Host: Alan S. Brown, MD, FNLA Guest: Janet Wright, MD Heart disease and stroke are two of the leading causes of death in the United States. The Department of Health and Human Services, with several key partners, launched the Million Hearts national public-private initiative. Million Hearts aims to prevent one million heart attacks and strokes over five years through behavioral changes and clinical interventions. Host Dr. Alan Brown welcomes Dr. Janet Wright, Executive Director of Million...

Duration:00:15:59

Dyslipidemia During Pregnancy: The Risks for Two Patients

9/22/2014
More
Host: Alan S. Brown, MD, FNLA An old clinical dogma in OB/GYN was that dyslipidemia during pregnancy wouldn't have any long term implications on the developing fetus because of short exposures at 9 months. This has since been shown to be untrue. What health issues surface in children whose mothers experienced abnormally elevated lipid levels in pregnancy, and how can these problems be prevented at the peripartum stage? Host Dr. Alan Brown joins Dr. Robert Wild, Professor of Obstetrics and...

Duration:00:14:59

Statin Intolerance: Keys to Patient Counseling and Guidance

9/22/2014
More
Host: Alan S. Brown, MD, FNLA As many as 25% of patients taking statins may experience side effects. How should clinicians respond to the broad spectrum of side effects and variable severities reported? Host Dr. Alan Brown welcomes Dr. John Guyton, Associate Professor of Medicine and Assistant Professor of Pathology at Duke University School of Medicine, to discuss statin intolerance and the most effective methods for counseling patients who experience this issue. Dr. Guyton's team has...

Duration:00:15:59

Roles of Non-HDL Cholesterol in Risk Assessment and Treatment

9/15/2014
More
Host: Alan S. Brown, MD, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-HDL cholesterol. What are the ramifications of this change in approach, and how does the NLA weigh in on recommendations for targets and goals? To address these and...

Duration:00:16:00

Keys to the Latest NLA Recommendations for Dyslipidemia Treatments

9/9/2014
More
Host: Alan S. Brown, MD, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations is Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty in Biostatistics and Applied...

Duration:00:15:30

Management of the Patient With Triglycerides 200-499 mg/dl.

8/26/2014
More
Host: Alan S. Brown, MD, FNLA Guest: Carl Orringer, MD, FACC, FNLA What are some of the causes of high triglycerides? What is the biggest health risk? And, for these patients, at what level is the risk greater for developing pancreatitis and coronary artery disease? Host Dr. Alan Brown welcomes Dr. Carl Orringer, Associate Professor of Medicine at the Cardiology Division, University of Miami Medical Center and Director of the Preventive Cardiovascular Medicine and LDL apheresis program....

Duration:00:15:00

What is the Safety of Statins in Patients with Diabetes?

5/13/2014
More
Host: Alan S. Brown, MD, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well...

Duration:00:12:29

A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines

5/13/2014
More
Host: Alan S. Brown, MD, FNLA Guest: Anne Goldberg, MD Host Dr. Alan Brown is joined by Anne Goldberg, MD, Associate Professor of Medicine at Washington University School of Medicine and a member of the ACC/AHA Blood Cholesterol Guidelines Panel. Dr. Goldberg will provide a review of the panel assembled by National Heart, Lung, and Blood Institute to construct integrated guidelines for cardiovascular risk reduction. She will also address the controversy regarding the ACC/AHA recently...

Duration:00:17:59

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia

5/8/2014
More
Host: Alan S. Brown, MD, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Carl Orringer, MD, FACC, FNLA Guest: Harold Bays, MD, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the...

Duration:00:30:00

New Insights on Statin Therapy for Older Patients

1/8/2014
More
Host: Alan S. Brown, MD, FNLA Is there a patient age at which statin therapy should be discontinued? Likewise, what does the current evidence tell us about initiating vs not initiating statin therapy in older patients? Joining Lipid Luminations to discuss these and other important questions is Dr. W. Virgil Brown, Charles Howard Candler Professor of Medicine Emeritus at Emory University School of Medicine in Atlanta, Georgia.

Duration:00:16:59

HPS-2 THRIVE Data and Results

1/7/2014
More
Host: Alan S. Brown, MD, FNLA Joining host Dr. Alan Brown is Dr. John Guyton, Associate Professor of Medicine and Assistant Professor of Pathology of the Division of Medicine-Endocrinology and Metabolism at Duke University School of Medicine. Their discussion will focus on data and results from HPS-2 THRIVE, a large-scale study comparing the use of statins and niacin versus statins alone. THRIVE stands for the Treatment of HDL to Reduce the Incidence of Vascular Events.

Duration:00:16:29

Health Information Technology's Impact on Adherence to Lipid Therapy

12/17/2013
More
Host: Alan S. Brown, MD, FNLA Health information technologies have evolved dramatically from simplistic documentation devices early on to sophisticated drivers of quality patient care today. This emergence is having a particularly positive effect on treatment for dyslipidemia. Joining host Dr. Alan Brown to reflect on a recent NLA manuscript of HIT's impact toward adherence to lipid therapy is Dr. Jerome Cohen, Emeritus Professor of Internal Medicine at Saint Louis University School of...

Duration:00:15:29

Cardiometabolic Consequences of Sitting Time

10/29/2013
More
Host: Alan S. Brown, MD, FNLA Host Dr. Alan Brown welcomes Dr. Marc Hamilton, Professor at Pennington Biomedical Research Center in Baton Rouge, LA. Their convesation focuses on the cardiometabolic consequences of lengthy sitting times, such as in people with "desk job careers."

Duration:00:15:59

Generics and Manufacturing: What Prescribers Need to Know

10/29/2013
More
Host: Alan S. Brown, MD, FNLA Joining host Dr. Alan Brown is Michael B. Bottorff, Pharm.D., Professor and Chair in the Department of Pharmacy Practice at South College School of Pharmacy in Knoxville, Tennessee. Dr. Bottorff will be reviewing generic medications, from manufacturing processes to approval measures.

Duration:00:14:00

Genetic Testing for Familial Hypercholesterolemia

10/21/2013
More
Host: Alan S. Brown, MD, FNLA Speaking with host Dr. Alan Brown on the state of genetic testing for familial hypercholesterolemia (FH) is Dr. Joshua W. Knowles, MD, PhD, Instructor of Cardiovascular Medicine at Stanford University and Attending Physician of the Stanford Center for Inherited Cardiovascular Disease Familial Hypercholesterolemia (FH) Clinic.

Duration:00:15:59

Research Updates in Familial Hypercholesterolemia

10/9/2013
More
Host: Alan S. Brown, MD, FNLA Dr. Alan Brown is joined by Dr. Bart Duell, director of the Lipid Disorders Clinic at the Oregon Health and Sciences University and one of the top winners in the NLA Abstracts program, to discuss research updates in Familial Hypercholesterolemia (FH).

Duration:00:14:59

Research Updates on Postprandial Dyslipidemia Treatment

9/23/2013
More
Host: Alan S. Brown, MD, FNLA Postprandial hypertriglyceridemia occurs when the rapid absorption of dietary fat (in the form of chylomicron triglycerides) overwhelms the body's ability to clear plasma triglyceride. In its most severe form, postprandial hypertriglyceridemia can lead to chylomicronemia and a greatly increased risk of acute, life-threatening pancreatitis. Joining host Dr. Alan Brown to talk about this condition and a trial drug treatment in research and development is Dr. Dan...

Duration:00:15:00

Lipid Biomarker Updates: When to Move Beyond the Standard Profile

9/23/2013
More
Host: Alan S. Brown, MD, FNLA Dr. Alan Brown is joined by Dr. Thomas Dayspring, Director of Cardiovascular Education for the Foundation for Health Improvement and Technology in Richmond, VA and clinical assistant professor of medicine at the UMDNJ - NJ Medical School. He is also a Fellow of both the American College of Physicians and the National Lipid Association. The two discuss Dr. Dayspring's research on discordances between LDL-P and ApoB, two biomarkers that are otherwise thought to...

Duration:00:15:00

What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patient

8/28/2013
More
Host: Alan S. Brown, MD, FNLA Dr. Alan Brown welcomes Dr. Daniel J. Rader, Cooper-McLure Professor of Medicine and Pharmacology and Chief of the Division of Translational Medicine and Human Genetics at the Perelman School of Medicine at the University of Pennsylvania. Their discussion focuses on the clinical diagnosis, genetic complexity and prevalence of HoFH while exploring the current and novel modalities available to help HoFH patients achieve their LDL goals. Produced in Partnership...

Duration:00:16:59

Adiposity, Obesity, and Dyslipidemia

8/21/2013
More
Host: Alan S. Brown, MD, FNLA Dr. Harold Bays, Chair for the National Lipid Association's expert panel on Adiposity, Obesity, and Dyslipidemia, discusses with host Dr. Alan Brown the panel's consensus statement published in the Journal of Clinical Lipidology.

Duration:00:16:29

Try Premium for 30 days

Live games for all NFL, MLB, NBA, & NHL teams
Commercial-Free Music
No Display Ads